Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Japan Medical Dynamic Marketing, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 39%
7600 Japan Medical Dynamic Marketing, INC. 【J-GAAP】
Earnings ReportJapan Medical Dynamic Marketing, INC. <7600> [TSE Prime] announced its financial results at noon (12:30) on October 30th. The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2026 (April to September) significantly dropped 80.4% from the same period last year to 0.13 billion yen.
In addition, the full-year forecast for consolidated ordinary profit has decreased 38.9%, from the previous forecast of 0.90 billion yen to 0.55 billion yen (compared to 1.48 billion yen in the previous period), leading to an increase in the profit decline rate from 39.5% to 63.0%.
Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to drop 49.0% from the same period last year to 0.42 billion yen.
In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit significantly dropped to 0.02 billion yen, a 91.6% decrease compared to the same period last year. The operating profit margin drastically worsened from 5.3% in the same period last year to 1.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2023 | 10,952 | 617 | 632 | 359 | 13.7 | 34.3 | Oct 30, 2023 | J-GAAP |
| Apr - Sep, 2024 | 11,817 | 669 | 664 | 496 | 18.9 | 44.6 | Oct 30, 2024 | J-GAAP |
| Apr - Sep, 2025 | 11,610 | 208 | 130 | 69 | 2.7 | 23.6 | Oct 30, 2025 | J-GAAP |
| YoY | -1.8% | -68.9% | -80.4% | -86.1% | -85.9% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 Guidance | 11,750 | 210 | 150 | 80 | 3.0 | 0 | Sep 5, 2025 | J-GAAP |
| Apr - Sep, 2025 Results | 11,610 | 208 | 130 | 69 | 2.7 | 0 | Oct 30, 2025 | J-GAAP |
| Revision Rate | -1.2% | -1.0% | -13.3% | -13.8% | -12.8% |
Guidance Update
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2026 Prev | 25,450 | 1,010 | 900 | 600 | 22.8 | 17 | Sep 5, 2025 | J-GAAP |
| Mar, 2026 New | 24,800 | 700 | 550 | 300 | 11.4 | 17 | Oct 30, 2025 | J-GAAP |
| Revision Rate | -2.6% | -30.7% | -38.9% | -50.0% | -50.0% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 13,297 | 886 | 824 | -957 | -36.4 | 15 | Apr 30, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 13,190 | 492 | 420 | 231 | 8.8 | 17 | Oct 30, 2025 | J-GAAP |
| YoY | -0.8% | -44.5% | -49.0% | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 23,177 | 1,746 | 1,842 | 1,271 | 48.3 | 14 | Apr 30, 2024 | J-GAAP |
| Mar, 2025 | 25,114 | 1,555 | 1,488 | -461 | -17.5 | 15 | Apr 30, 2025 | J-GAAP |
| Mar, 2026 Guidance | 24,800 | 700 | 550 | 300 | 11.4 | 17 | Oct 30, 2025 | J-GAAP |
| YoY | -1.3% | -55.0% | -63.0% | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 5,765 | 303 | 297 | 223 | 8.5 | 5.3 | Oct 30, 2024 | J-GAAP |
| Oct - Dec, 2024 | 6,641 | 560 | 530 | 383 | 14.6 | 8.4 | Jan 30, 2025 | J-GAAP |
| Jan - Mar, 2025 | 6,656 | 326 | 294 | -1,340 | -51.0 | 4.9 | Apr 30, 2025 | J-GAAP |
| Apr - Jun, 2025 | 5,920 | 150 | 105 | 65 | 2.5 | 2.5 | Jul 30, 2025 | J-GAAP |
| Jul - Sep, 2025 | 5,690 | 58 | 25 | 4 | 0.2 | 1.0 | Oct 30, 2025 | J-GAAP |
| YoY | -1.3% | -80.9% | -91.6% | -98.2% | -98.2% |
Related Articles
OSAKA STEEL, Jul-Sep (2Q) Ordinary Profit Turns to Profit
DAIHATSU DIESEL MFG, First Half Ordinary Profit Decreases by 17%
TOMEN DEVICES, Ordinary Profit Forecast for the Fiscal Year Revised Upward to an Unexpected 22% Increase, Highest in Four Terms, Dividend Revised Upward by 40 Yen
Ichiyoshi Securities, First Half Ordinary Profit Increases by 20%, Jul-Sep Ordinary Profit Increases by 2.2 times
Okura Industrial, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 38%, Jul-Sep Ordinary Profit Increases by 68%
Sojitz, First Half Net Income Increases by 2%
Sumitomo Riko, Net Income Forecast for the Fiscal Year Revised Upward by 3%, Second Half Dividend Postponed
Japan Airlines, First Half Net Income Increases by 36%, Jul-Sep Net Income Increases by 13%
Marusan Securities, Jul-Sep (2Q) Ordinary Profit Increases by 41%
ONO PHARMA, First Half Net Income Increases by 7%, Jul-Sep Net Income Increases by 77%